# Neuranics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neuranics

- Industry: Medical Devices & Equipment
- Headquarters: Glasgow, UK
- Website: www.neuranics.com/
- Total disclosed funding: $9M
- Latest round: Seed (Apr 25, 2025)
- Investors on record: 6

## About

Based in Scotland, UK, and founded in 2021, Neuranics operates as a neurotechnology company that develops wearable and implantable human-computer interfaces. The company was co-founded by Kia Nazarpour, Hadi Heidari, and Siming Zuo. As of January 2024, the company is led by Noel McKenna (CEO). In April 2025, Neuranics Limited raised USD 8 million led by Blackfinch Ventures, with participation from Archangels Investors Limited, Par Equity, University of Glasgow, and Old College Capital. The company's main product is miniaturized sensors that can measure and record magnetic fields from the human body. Neuranics aims to create the everyday human-computer interface and bring a multitude of disease diagnoses with its AI-based diagnostic device. The company's technology surpasses existing constraints in health monitoring and human-machine interfaces and uses minimal power consumption.

The company will use the April 2025 funding to accelerate global growth and the commercial adoption of its tunnelling magnetoresistance (TMR) magnetic sensing technology.

## Funding rounds

- Seed, Apr 25, 2025, $8.3M — Archangels Investors Limited, PXN Group, University of Glasgow, Old College Capital, Blackfinch Ventures
- Seed, Dec 5, 2024, $0.7M — Inflection Point Ventures

## Investors

- Inflection Point Ventures (https://capitalatlas.ai/funds/inflection-point-ventures) — Seed
- Archangels Investors Limited — Seed
- PXN Group (https://capitalatlas.ai/funds/pxn-group) — Seed
- University of Glasgow — Seed
- Old College Capital (https://capitalatlas.ai/funds/old-college-capital) — Seed
- Blackfinch Ventures (https://capitalatlas.ai/funds/blackfinch-ventures) — Seed